Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|June 25, 2009
Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment optionsJanine Marie Davies, Bert O'NeilClinical Advances in Hematology & Oncology : H&O|April 9, 2008
Targeted therapies for hepatocellular carcinomaMatthew R Skelton, Bert O'NeilThe Oncologist|April 12, 2013
Antiangiogenic therapies for advanced hepatocellular carcinomaKeeran R Sampat, Bert O'NeilCancer Immunology, Immunotherapy : CII|June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186Cameron J Herting, Matthew R Farren, Yan Tong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.Clinical Case Reports|July 11, 2018
Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinomaIhab I El Hajj, Karen A Lawrence, Temel Tirkes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2017
A systematic review of psychosocial interventions for colorectal cancer patientsCatherine E Mosher, Joseph G Winger, Barbara A Given, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational BurdenOlumide Gbolahan, Neda Hashemi-Sadraei, Bert O'NeilThe Oncologist|June 4, 2016
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular CarcinomaSafi Shahda, Patrick J Loehrer, Romnee S Clark, et al.Cancers|October 31, 2018
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer MetastasisDongsheng Gu, Hai Lin, Xiaoli Zhang, et al.Pageof 7